Celgene Hit With Suit For Blocking Generic Cancer Drugs
By Jessica Corso ( March 4, 2015, 7:02 PM EST) -- The City of Providence is leading a putative class of consumers who accuse Celgene Corp. in a New Jersey federal suit filed Tuesday of monopolizing the market for two blockbuster cancer drugs by blocking competitors' access to samples needed to bring a generic to market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.